0000899243-22-020399.txt : 20220601
0000899243-22-020399.hdr.sgml : 20220601
20220601162319
ACCESSION NUMBER: 0000899243-22-020399
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220527
FILED AS OF DATE: 20220601
DATE AS OF CHANGE: 20220601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Michael Edward L.
CENTRAL INDEX KEY: 0001391823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 22987650
MAIL ADDRESS:
STREET 1: 618 SHERIDAN SQUARE
CITY: EVANSTON
STATE: IL
ZIP: 60202
FORMER NAME:
FORMER CONFORMED NAME: Michael Edward L
DATE OF NAME CHANGE: 20070301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-27
1
0000353569
QUIDEL CORP /DE/
QDEL
0001391823
Michael Edward L.
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2022-05-27
4
D
0
9098
D
0
D
Restricted Stock Units
2022-05-27
4
D
0
1137
0.00
D
Common Stock
1137
0
D
Restricted Stock Units
2022-05-27
4
D
0
341
0.00
D
Common Stock
341
0
D
Restricted Stock Units
2022-05-27
4
D
0
356
0.00
D
Common Stock
356
0
D
Restricted Stock Units
2022-05-27
4
D
0
106
0.00
D
Common Stock
106
0
D
Restricted Stock Units
2022-05-27
4
D
0
555
0.00
D
Common Stock
555
0
D
Restricted Stock Units
2022-05-27
4
D
0
166
0.00
D
Common Stock
166
0
D
Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
Each restricted stock unit represents the right to receive one share of Quidel common stock.
Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule.
/s/ Phillip S. Askim, attorney-in-fact for Edward L. Michael
2022-06-01